Biceps femoris muscle was a potentially useful alternative specimen in one postmortem MDMA rat experiment, but the study did not validate muscle as an interchangeable substitute for human blood. Relatively low and stable concentrations were a specimen-selection observation, not proof that the muscle preserved a concentration during life.
What was the exposure model?
Liang and colleagues randomly assigned 720 male Sprague–Dawley rats, approximately 200 ± 10 g, to four groups of 180. Two groups received 20% ethanol–water as their only drinking liquid for four weeks; two received water. One group from each drinking condition then received intragastric MDMA at 150 mg/kg, and the other groups received saline.
All rats were killed by neck concussion 30 minutes after dosing. This short interval matters: the investigators acknowledged that drug distribution and elimination could still have been ongoing. The experiment was not a study of naturally occurring human overdose deaths and did not demonstrate that MDMA caused the rats’ deaths.
Bodies were stored at either 20°C with 70% humidity or 0°C with 50% humidity. Six animals per exposure group and storage condition supplied specimens at each of 15 postmortem times from zero through ten days. Different animals supplied different times; this was not serial muscle sampling from the same rat.
Why did the authors consider biceps femoris useful?
The investigators measured heart blood, vitreous, urine and eight tissues, including biceps femoris muscle. They described comparatively low MDMA levels in muscle and vitreous, while several abdominal organs had higher concentrations. They considered biceps femoris relatively stable and less subject to diffusion from adjacent drug-rich organs.
Its anatomical distance from major abdominal reservoirs was a proposed explanation. The study did not directly trace MDMA movement into each muscle specimen or quantify the contribution of every mechanism. Low concentration could not by itself establish absence of redistribution.
The authors suggested muscle might be useful when usual specimens were unavailable or putrefaction advanced. That recommendation came from this animal protocol; it did not establish a human diagnostic accuracy, blood-prediction interval or impairment cutoff.
The muscle findings still changed
In the ethanol-plus-MDMA group, Table 5 placed the muscle concentration peak at day two under both body-storage environments. In the MDMA-only group, the reported peak shifted from 24 hours at 20°C to day two at 0°C. Relatively stable therefore did not mean unchanging.
The table’s colder-to-warmer peak ratios were 0.880 for the combined-exposure muscle group and 0.951 for the MDMA-only muscle group. These compared group maxima, potentially occurring at different times. They were not paired measurements of loss from the same stored vial, blood-to-muscle conversion factors or demonstrations of statistical equivalence.
The study reported significant concentration variation over the ten-day investigation by MANOVA, p < 0.01. It did not establish that every individual muscle contrast was statistically significant. Temperature and humidity also changed together, limiting attribution to cooling alone.
What did the analytical method support?
Tissue preparation used a 1 g homogenized sample, extraction and derivatization, followed by gas chromatography with electron-capture detection. This was not mass-spectrometric confirmation. Table 3 gave muscle calibration of 0.5–50 µg/g, correlation coefficient 0.9992 and detection limit 5 ng/g.
A detection limit is not automatically a quantification limit. The report did not provide a distinct muscle quantification-limit value that could be substituted for the reported detection limit or lowest calibration point.
The detailed precision table concerned blood. Its favorable blood results should not be relabeled as a complete muscle-specific validation. Tissue concentrations in µg/g also remain different measurands from fluid concentrations in µg/mL. Collected specimens were stored at −70°C until analysis, separately from the bodies’ earlier storage conditions.
What can be carried into a case review?
Muscle may add analytical evidence when blood is unavailable, but interpretation must retain species, exact muscle, collection time, units and method scope. The experiment supplied no equation recovering human blood concentration, administered dose or predeath impairment from muscle MDMA. Drug detection alone did not establish cause of death.
For another preparation-related limit, see how muscle homogenization and dilution affect reportable drug results.
Primary source
Liang M, Zhang J, Zheng N, Liu L. How Postmortem Redistribution of MDMA in Acute Alcohol-MDMA Combined-Use Rats Change under Effects of Alcohol. Scientific Reports. 2017;7:4038. doi:10.1038/s41598-017-04416-y.
Leave a Reply